share_log

康希诺(688185.SH):冻干b型流感嗜血杆菌结合疫苗获得药物临床试验批准通知书

Cansino (688185.SH): Freeze-dried Haemophilus influenzae type b conjugate vaccine obtained drug clinical trial approval notice

Gelonghui Finance ·  Apr 22 06:08

Gelonghui, April 22丨Cansino (688185.SH) announced that it recently received the “Drug Clinical Trial Approval Notice” for the freeze-dried Haemophilus influenzae type b conjugate vaccine (“Hib vaccine”) approved and issued by the State Drug Administration. The Hib vaccine developed by the company is a covalent combination of purified Hib capsular polysaccharide and tetanus toxoid protein. It is expected to induce humoral immunity against Hib after vaccination and provide protection to vaccinators.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment